Avista concludes purchase of Bristol-Myers Squibb Medical Imaging

Avista Capital Partners, a Houston-based equity firm, has completed its acquisition of Bristol-Myers Squibb (BMS) Medical Imaging.

BMS Medical Imaging, based in Billerica, Mass.,  provides medical imaging products focused on cardiovascular diagnostic imaging to nuclear physicians, cardiologists, radiologists, internal medicine physicians, IDNs/GPOs and technologists/sonographers working in hospitals and outpatient clinics, according to .

BMS said the company supplies its products to hospitals, clinics and radiopharmacies in the United States, as well as internationally, including Australia and Canada.

JP Morgan Securities served as financial advisor for BMS and Cravath, Swaine & Moore served as its legal counsel. Weil, Gotshal & Manges served as legal counsel for Avista Capital Partners.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.